Financhill
Back

Perspective Therapeutics Vs. Target Industry Stock Comparison

Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
22

TGT
Target

Last Price:
125.00
Seasonality Move:
4.08%
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Target (TGT) is a Sell

Is Target a Buy, Sell or Hold?

  • The current Target [TGT] share price is $125.01. The Score for TGT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • TGT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

TGT Stock Price Chart

What is Target's stock price today?

  • The Target share price today is $125.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TGT is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

TGT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.11 Sell
Relative Strength Index (14 RSI): 28.67 Sell
Chaikin Money Flow: 9125665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (138.23 - 157.41) Sell
Bollinger Bands (100): (141.76 - 157.14) Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

TGT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 142.68 Sell
20-day SMA: 147.3 Sell
50-day SMA: 151.17 Sell
200-day SMA: 153.74 Sell
8-day EMA: 137.63 Sell
20-day EMA: 145.05 Sell
50-day EMA: 148.83 Sell
200-day EMA: 149.38 Sell

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Target Earnings Growth & TGT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.33 per share, an increase this year of $2.81 per share, and an increase next year of $0.33 per share.

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Target Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):